T1	p 126 150	deep venous thrombosis .
T2	p 167 211	postoperative deep venous thrombosis ( DVT )
T3	p 1105 1267	surgical patients including those undergoing noncardiac thoracic and pelvic operations who were identified at moderate to high risk for postop DVT were included .
T4	p 1462 1541	hundred and eighty eight patients were entered into this trial and 744 ( 85 % )
T5	i 547 572	dihydroergotamine ( DHE )
T6	i 577 584	heparin
T7	i 982 1096	DHE 0.5 mg plus heparin 5000 U , DHE 0.5 mg plus heparin 2500 U , heparin 5000 U , and DHE 0.5 mg versus placebo .
T8	i 1645 1652	placebo
T9	o 181 203	deep venous thrombosis